These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15791514)

  • 41. Voriconazole in newborns.
    Kohli V; Taneja V; Sachdev P; Joshi R
    Indian Pediatr; 2008 Mar; 45(3):236-8. PubMed ID: 18367773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis.
    Choi SH; Lee SY; Hwang JY; Lee SH; Yoo KH; Sung KW; Koo HH; Kim YJ
    Pediatr Blood Cancer; 2013 Jan; 60(1):82-7. PubMed ID: 22887791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Voriconazole-induced neuropathy.
    Aksoy F; Akdogan E; Aydin K; Yilmaz M; Altunayoglu V; Sozen EE; Omay SB; Koksal I
    Chemotherapy; 2008; 54(3):224-7. PubMed ID: 18560230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP
    Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
    den Hollander JG; van Arkel C; Rijnders BJ; Lugtenburg PJ; de Marie S; Levin MD
    J Antimicrob Chemother; 2006 Jun; 57(6):1248-50. PubMed ID: 16556632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.
    Parize P; Chandesris MO; Lanternier F; Poirée S; Viard JP; Bienvenu B; Mimoun M; Méchai F; Mamzer MF; Herman P; Bougnoux ME; Lecuit M; Lortholary O
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1048-53. PubMed ID: 19104029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acremonium vertebral osteomyelitis: molecular diagnosis and response to voriconazole.
    Keynan Y; Sprecher H; Weber G
    Clin Infect Dis; 2007 Jul; 45(1):e5-6. PubMed ID: 17554690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
    Trifilio S; Singhal S; Williams S; Frankfurt O; Gordon L; Evens A; Winter J; Tallman M; Pi J; Mehta J
    Bone Marrow Transplant; 2007 Sep; 40(5):451-6. PubMed ID: 17589527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients.
    Cordonnier C; Maury S; Pautas C; Bastié JN; Chehata S; Castaigne S; Kuentz M; Bretagne S; Ribaud P
    Bone Marrow Transplant; 2004 May; 33(9):943-8. PubMed ID: 15034546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
    Kobayashi K; Kami M; Murashige N; Kishi Y; Fujisaki G; Mitamura T
    Haematologica; 2004 Nov; 89(11):ECR42. PubMed ID: 15533847
    [No Abstract]   [Full Text] [Related]  

  • 51. [A case of orbital apex syndrome caused by localized invasive aspergillosis successfully treated with voriconazole].
    Kuga A; Oishi K; Ishida H; Kanda F
    Rinsho Shinkeigaku; 2007 May; 47(5):207-10. PubMed ID: 17585601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral neuropathy in patients on long-term triazole antifungal therapy.
    Baxter CG; Marshall A; Roberts M; Felton TW; Denning DW
    J Antimicrob Chemother; 2011 Sep; 66(9):2136-9. PubMed ID: 21685202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
    Klein KC; Blackwood RA
    Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
    Saito T; Fujiuchi S; Tao Y; Sasaki Y; Ogawa K; Suzuki K; Tada A; Kuba M; Kato T; Kawabata M; Kurashima A; Sakatani M;
    Infection; 2012 Dec; 40(6):661-7. PubMed ID: 22956473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.
    Park WB; Kim NH; Kim KH; Lee SH; Nam WS; Yoon SH; Song KH; Choe PG; Kim NJ; Jang IJ; Oh MD; Yu KS
    Clin Infect Dis; 2012 Oct; 55(8):1080-7. PubMed ID: 22761409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
    Siwek GT; Pfaller MA; Polgreen PM; Cobb S; Hoth P; Magalheas-Silverman M; Diekema DJ
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):209-12. PubMed ID: 16626917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
    Gutierrez F; Masia M; Ramos JM; Elia M; Rodriguez-Tudela JL; Cuenca-Estrella M
    Clin Infect Dis; 2005 Jun; 40(11):1706-7. PubMed ID: 15889381
    [No Abstract]   [Full Text] [Related]  

  • 58. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
    Steinbach WJ; Benjamin DK; Kontoyiannis DP; Perfect JR; Lutsar I; Marr KA; Lionakis MS; Torres HA; Jafri H; Walsh TJ
    Clin Infect Dis; 2004 Jul; 39(2):192-8. PubMed ID: 15307028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole.
    Reis LJ; Barton TD; Pochettino A; Velazquez O; McGarvey M; Milas B; Reboli A; Schuster MG
    Clin Infect Dis; 2005 Sep; 41(5):752-3. PubMed ID: 16080100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
    Uriz J; de Andoin NG; Calvo C; Landa J; Onate E; Nogues A; Guerrero R
    Pediatr Infect Dis J; 2007 Oct; 26(10):971-2. PubMed ID: 17901816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.